Idazoxan XR

About Terran Biosciences

Terran Biosciences is a private, platform-based biotechnology company pioneering a multi-faceted approach to neuroscience. Its strategy integrates late-stage clinical assets, a broad psychedelic and empathogen development program, advanced drug design capabilities, and a commercial AI software platform for neuroimaging. With a pipeline featuring several late-stage programs for schizophrenia and Alzheimer's disease, and key partnerships with Sanofi and Pierre Fabre, Terran is positioned to address significant unmet needs in psychiatry and neurology. The company operates as a pre-revenue entity, advancing its diverse portfolio through strategic licensing, internal R&D, and its first FDA-cleared software product.

Therapeutic Areas